These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34752778)

  • 1. The relationship between hormonal contraception and cervical dysplasia/cancer controlling for human papillomavirus infection: A systematic review.
    Anastasiou E; McCarthy KJ; Gollub EL; Ralph L; van de Wijgert JHHM; Jones HE
    Contraception; 2022 Mar; 107():1-9. PubMed ID: 34752778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal contraceptive use and smoking as risk factors for high-grade cervical intraepithelial neoplasia in unvaccinated women aged 30-44 years: A case-control study in New South Wales, Australia.
    Xu H; Egger S; Velentzis LS; O'Connell DL; Banks E; Darlington-Brown J; Canfell K; Sitas F
    Cancer Epidemiol; 2018 Aug; 55():162-169. PubMed ID: 29980028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of high-risk HPV and cervical dysplasia in IUD users and controls: a cross sectional study.
    Jans L; Brynhildsen J; Cherif E; Tenerz L; Bergengren L
    Eur J Contracept Reprod Health Care; 2024 Jun; 29(3):109-114. PubMed ID: 38666336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of the use of oral contraceptives as risk factors for human papillomavirus infection and cervical intraepithelial neoplasia].
    Salazar EL; González JL; Olmos A; Calzada L
    Ginecol Obstet Mex; 2005 Feb; 73(2):83-9. PubMed ID: 21961342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study.
    Loopik DL; IntHout J; Melchers WJG; Massuger LFAG; Bekkers RLM; Siebers AG
    Eur J Cancer; 2020 Jan; 124():102-109. PubMed ID: 31760309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort.
    Roura E; Travier N; Waterboer T; de Sanjosé S; Bosch FX; Pawlita M; Pala V; Weiderpass E; Margall N; Dillner J; Gram IT; Tjønneland A; Munk C; Palli D; Khaw KT; Overvad K; Clavel-Chapelon F; Mesrine S; Fournier A; Fortner RT; Ose J; Steffen A; Trichopoulou A; Lagiou P; Orfanos P; Masala G; Tumino R; Sacerdote C; Polidoro S; Mattiello A; Lund E; Peeters PH; Bueno-de-Mesquita HB; Quirós JR; Sánchez MJ; Navarro C; Barricarte A; Larrañaga N; Ekström J; Lindquist D; Idahl A; Travis RC; Merritt MA; Gunter MJ; Rinaldi S; Tommasino M; Franceschi S; Riboli E; Castellsagué X
    PLoS One; 2016; 11(1):e0147029. PubMed ID: 26808155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroidal contraceptives and bone fractures in women: evidence from observational studies.
    Lopez LM; Chen M; Mullins S; Curtis KM; Helmerhorst FM
    Cochrane Database Syst Rev; 2012 Aug; (8):CD009849. PubMed ID: 22895991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology.
    Castle PE; Walker JL; Schiffman M; Wheeler CM
    Int J Cancer; 2005 Dec; 117(6):1007-12. PubMed ID: 15986443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal contraceptives and the length of their use are not independent risk factors for high-risk HPV infections or high-grade CIN.
    Longatto-Filho A; Hammes LS; Sarian LO; Roteli-Martins C; Derchain SF; Eržen M; Branca M; Tatti S; Naud P; de Matos JC; Gontijo R; Maeda MY; Lima T; Costa S; Syrjänen S; Syrjänen K
    Gynecol Obstet Invest; 2011; 71(2):93-103. PubMed ID: 21150159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous progestins and breast cancer.
    Stanford JL; Thomas DB
    Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical dysplasia and cancer and the use of hormonal contraceptives in Jamaican women.
    McFarlane-Anderson N; Bazuaye PE; Jackson MD; Smikle M; Fletcher HM
    BMC Womens Health; 2008 May; 8():9. PubMed ID: 18513406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives are not an independent risk factor for cervical intraepithelial neoplasia or high-risk human papillomavirus infections.
    Syrjänen K; Shabalova I; Petrovichev N; Kozachenko V; Zakharova T; Pajanidi J; Podistov J; Chemeris G; Sozaeva L; Lipova E; Tsidaeva I; Ivanchenko O; Pshepurko A; Zakharenko S; Nerovjna R; Kljukina L; Erokhina O; Branovskaja M; Nikitina M; Grunberga V; Grunberg A; Juschenko A; Santopietro R; Cintorino M; Tosi P; Syrjanen S
    Anticancer Res; 2006; 26(6C):4729-40. PubMed ID: 17214333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection.
    Harris TG; Miller L; Kulasingam SL; Feng Q; Kiviat NB; Schwartz SM; Koutsky LA
    Am J Obstet Gynecol; 2009 May; 200(5):489.e1-8. PubMed ID: 19375566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
    Vessey MP; Lawless M; McPherson K; Yeates D
    Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of hormonal contraceptives among women with migraine: A systematic review.
    Tepper NK; Whiteman MK; Zapata LB; Marchbanks PA; Curtis KM
    Contraception; 2016 Dec; 94(6):630-640. PubMed ID: 27153744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Young women, cervical intraepithelial neoplasia and human papillomavirus: risk factors for persistence and recurrence.
    Frega A; Stentella P; De Ioris A; Piazze JJ; Fambrini M; Marchionni M; Cosmi EV
    Cancer Lett; 2003 Jul; 196(2):127-34. PubMed ID: 12860270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal contraceptives, human papillomaviruses and cervical cancer; some observations from a colposcopy clinic.
    Chang AR
    Aust N Z J Obstet Gynaecol; 1989 Aug; 29(3 Pt 2):329-31. PubMed ID: 2559710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Masking effect of hormonal contraceptives on discriminating quantitative features of visually normal intermediate cells in positive and negative cervical smears.
    Kwikkel HJ; Boon ME; van Rijswijk MM; Rietveld WJ; Stolk JG
    Anal Quant Cytol Histol; 1986 Sep; 8(3):227-32. PubMed ID: 3778614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal Contraceptives and the Acquisition of Sexually Transmitted Infections: An Updated Systematic Review.
    McCarthy KJ; Gollub EL; Ralph L; van de Wijgert J; Jones HE
    Sex Transm Dis; 2019 May; 46(5):290-296. PubMed ID: 30628946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal and barrier methods of contraception, oncogenic human papillomaviruses, and cervical squamous intraepithelial lesion development.
    Coker AL; Sanders LC; Bond SM; Gerasimova T; Pirisi L
    J Womens Health Gend Based Med; 2001 Jun; 10(5):441-9. PubMed ID: 11445043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.